peptidoleukotriene

the release of peptidoleukotriene contributes significantly to bronchoconstriction in asthmatic patients.

researchers observed that peptidoleukotriene production increases during allergic reactions.

antagonists blocking the peptidoleukotriene receptor are effective treatments for allergic rhinitis.

biosynthesis of peptidoleukotriene depends on the 5-lipoxygenase pathway in inflammatory cells.

increased peptidoleukotriene levels were detected in the sputum of chronic bronchitis sufferers.

pharmacological inhibition of peptidoleukotriene action reduces airway inflammation significantly.

ltc4 is a major peptidoleukotriene involved in the pathogenesis of asthma.

the study examined peptidoleukotriene metabolism in patients with aspirin-exacerbated respiratory disease.

specific assays are required to accurately measure peptidoleukotriene concentration in blood samples.

scientists are investigating the role of peptidoleukotriene signaling in pulmonary fibrosis.

mast cells are a primary source of peptidoleukotriene release during anaphylaxis.

genetic variations can affect peptidoleukotriene receptor sensitivity among different individuals.